The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Baseline demographics of the randomized, placebo-controlled, double-blind, phase III RADIANT-4 study of everolimus in nonfunctional gastrointestinal (GI) or lung neuroendocrine tumors (NET).
 
James C. Yao
Consulting or Advisory Role - Ipsen; Lexicon; Novartis
Research Funding - Novartis (Inst)
 
Roberto Buzzoni
Research Funding - Italfarmaco (Inst); Novartis (Inst); Otsuka (Inst)
Travel, Accommodations, Expenses - Ipsen; Italfarmaco; Novartis
 
Carlo Carnaghi
No Relationships to Disclose
 
Nicola Fazio
Honoraria - Ipsen; Novartis
Consulting or Advisory Role - Celgene; Ipsen; Lexicon; Novartis
 
Simron Singh
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Edward M. Wolin
Consulting or Advisory Role - Celgene; Ipsen; Novartis
 
Jiri Tomasek
Honoraria - Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Markus Raderer
Honoraria - Celgene; Ipsen; Novartis; Roche
Consulting or Advisory Role - Celgene; Ipsen; Novartis; Roche
 
Harald Lahner
Honoraria - Ipsen; Novartis; Pfizer
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer
 
Du Hung Lam
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Research Funding - Novartis
 
Helene Cauwel
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Juan W. Valle
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst)
 
Gianfranco Delle Fave
Consulting or Advisory Role - Novartis
Research Funding - Novartis
 
Eric Van Cutsem
Research Funding - Novartis (Inst)
 
Jonathan R. Strosberg
Honoraria - Novartis
Consulting or Advisory Role - Ipsen; Lexicon; Novartis
Speakers' Bureau - Bayer; Genentech
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Margot Et Tesselaar
No Relationships to Disclose
 
Yasuhiro Shimada
Research Funding - Chugai Pharma (Inst); Lilly (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
 
Do-Youn Oh
No Relationships to Disclose
 
Matthew Kulke
Consulting or Advisory Role - Ipsen; Novartis
 
Marianne E. Pavel
Honoraria - Ipsen; Lexicon; Novartis; Pfizer
Consulting or Advisory Role - Ipsen; Lexicon; Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Ipsen; Novartis